GlyCosmos Portal

GlyCosmos PubAnnotations

Recent publication annotations of glycans, cell types, and proteins, from PubAnnotation.

Displaying entries **15226 - 15250** of **24862** in total

« First

‹ Prev

…

606

607

608

609

610

611

612

613

614

…

Next ›

Last »
Title ▼	Authors	PubMed ID	Source	Publication Year
Heparin-binding properties of vitronectin are linked to complex formation as illustrated by in vitro polymerization and binding to the terminal complement complex.	Høgåsen K Mollnes TE Harboe M	1385412	J Biol Chem	1992
Heparin-binding properties of the amyloidogenic peptides Abeta and amylin. Dependence on aggregation state and inhibition by Congo red.	Watson DJ Lander AD Selkoe DJ	9395501	J Biol Chem	1997
Heparin-binding properties of human serum spreading factor.	Barnes DW Reing JE Amos B	2410408	J Biol Chem	1985
Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity.	Murphy-Ullrich JE Gurusiddappa S Frazier WA Höök M	8253815	J Biol Chem	1993
Heparin-binding peptides from the type I repeats of thrombospondin. Structural requirements for heparin binding and promotion of melanoma cell adhesion and chemotaxis.	Guo NH Krutzsch HC Nègre E Zabrenetzky VS Roberts DD	1527055	J Biol Chem	1992
Heparin-binding histidine and lysine residues of rat selenoprotein P.	Hondal RJ Ma S Caprioli RM Hill KE Burk RF	11278668	J Biol Chem	2001
Heparin-binding growth-associated molecule contains two heparin-binding beta -sheet domains that are homologous to the thrombospondin type I repeat.	Kilpelainen I Kaksonen M Kinnunen T Avikainen H Fath M Linhardt RJ Raulo E Rauvala H	10788472	J Biol Chem	2000
Heparin-binding growth factor-1 stimulation of human endothelial cells induces platelet-derived growth factor A-chain gene expression.	Gay CG Winkles JA	1689299	J Biol Chem	1990
Heparin-binding growth factor-1 modulation of plasminogen activator inhibitor-1 expression. Interaction with cAMP and protein kinase C-mediated pathways.	Konkle BA Kollros PR Kelly MD	1701436	J Biol Chem	1990
Heparin-binding growth factor, pleiotrophin, mediates neuritogenic activity of embryonic pig brain-derived chondroitin sulfate/dermatan sulfate hybrid chains.	Bao X Mikami T Yamada S Faissner A Muramatsu T Sugahara K	15632143	J Biol Chem	2005
Heparin-binding epidermal growth factor-like growth factor links hepatocyte priming with cell cycle progression during liver regeneration.	Mitchell C Nivison M Jackson LF Fox R Lee DC Campbell JS Fausto N	15536070	J Biol Chem	2005
Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes.	Hashimoto K Higashiyama S Asada H Hashimura E Kobayashi T Sudo K Nakagawa T Damm D Yoshikawa K Taniguchi N	8051092	J Biol Chem	1994
Heparin-binding epidermal growth factor-like growth factor expression in cultured fetal human vascular smooth muscle cells. Induction of mRNA levels and secretion of active mitogen.	Dluz SM Higashiyama S Damm D Abraham JA Klagsbrun M	8349708	J Biol Chem	1993
Heparin, sulfated heparinoids, and lipoteichoic acids bind to the 70-kDa peptidoglycan/lipopolysaccharide receptor protein on lymphocytes.	Dziarski R Gupta D	8294463	J Biol Chem	1994
Heparin, heparan sulfate, and dermatan sulfate regulate formation of the insulin-like growth factor-I and insulin-like growth factor-binding protein complexes.	Arai T Parker A Busby W Jr Clemmons DR	7519608	J Biol Chem	1994
Heparin, carboxyl-reduced sulfated heparin, and Trestatin A sulfate. Antiproliferative and anticoagulant activities.	Wessel HP Hosang M Tschopp TB Weimann BJ	2279243	Carbohydr Res	1990
Heparin with two binding sites for antithrombin or platelet factor 4.	Jordan RE Favreau LV Braswell EH Rosenberg RD	7053378	J Biol Chem	1982
Heparin type IV collagen interactions: equilibrium binding and inhibition of type IV collagen self-assembly.	Tsilibary EC Koliakos GG Charonis AS Vogel AM Reger LA Furcht LT	3198614	J Biol Chem	1988
Heparin trisaccharides with nonreducing 2-amino-2-deoxy-alpha-D-glucopyranosyl end-groups suitable as substrates for catabolic enzymes.	Weissmann B Chao H	3791294	Carbohydr Res	1986
Heparin synergistically enhances interleukin-11 signaling through up-regulation of the MAPK pathway.	Rajgopal R Butcher M Weitz JI Shaughnessy SG	16720575	J Biol Chem	2006
Heparin suppresses specific second messenger pathways for protooncogene expression in rat vascular smooth muscle cells.	Pukac LA Ottlinger ME Karnovsky MJ	1371276	J Biol Chem	1992
Heparin strongly enhances the formation of beta2-microglobulin amyloid fibrils in the presence of type I collagen.	Relini A De Stefano S Torrassa S Cavalleri O Rolandi R Gliozzi A Giorgetti S Raimondi S Marchese L Verga L Rossi A Stoppini M Bellotti V	18056266	J Biol Chem	2008
Heparin strongly decreases the rate of inhibition of neutrophil elastase by alpha 1-proteinase inhibitor.	Frommherz KJ Faller B Bieth JG	1869557	J Biol Chem	1991
Heparin sequencing.	Stringer SE Kandola BS Pye DA Gallagher JT	12626406	Glycobiology	2003
Heparin selectively inhibits the transcription of tissue-type plasminogen activator in primate arterial smooth muscle cells during mitogenesis.	Au YP Kenagy RD Clowes AW	1310687	J Biol Chem	1992

Download data in CSV format Download data in TSV format Download data in JSON format

Table Filtering

GlyTouCan

GlyComb

GlycoPOST

UniCarb-DR

All Resources

Other Information

Tools

Search Tools

International Collaboration

Acknowledgements